Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Real-World Experience With Mavacamten in SRT-Eligible Obstructive HCM.
Journal: JACC. Advances
Published: April 08, 2026
Long-Term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM.
Journal: European journal of heart failure
Published: February 18, 2026
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.
Journal: Journal of cardiac failure
Published: October 16, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.
Journal: medRxiv : the preprint server for health sciences
Published: September 26, 2025
Comprehensive Plasma Proteomic Profiling Reveals Differentially Regulated Signaling Pathways Underlying Left Ventricular Hypertrophy Between Hypertrophic Cardiomyopathy and Aortic Stenosis.
Journal: Journal of cardiovascular translational research
Published: May 30, 2024
Incidence and recurrence of atrial fibrillation among patients with obstructive hypertrophic cardiomyopathy treated with mavacamten: a single-center experience.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: April 30, 2024
Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using plasma proteomics profiling.
Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Published: April 02, 2024
Evolving Strategies for the Management of Obstructive Hypertrophic Cardiomyopathy.
Journal: Journal of cardiac failure
Published: February 14, 2024
Myocardial Recovery With HeartMate 3 Left Ventricular Assist Device: An Attainable Goal That Needs Better Precision.
Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)
Published: November 14, 2023
Patient experiences in receiving telegenetics care for inherited cardiovascular diseases.
Journal: Journal of community genetics
Published: July 26, 2023
Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways.
Journal: Circulation. Heart failure
Published: June 12, 2023
Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics.
Journal: Heart (British Cardiac Society)
Published: March 13, 2023
Last Updated: 09/26/2026